1-4 of 4
hydralazine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Ramiro Espinoza, MD, Manuel Aguilar Rodríguez, MD, Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Resident, Diana Berenice Nolasco, MD, Silvia Eugenia Alarcon Barrios, Eduardo Cervera, Myrna Candelaria, MD PhD, Valentin Lozano, Alejandro Sosa, Javier Espinoza, Magnolia Vieyra, Jorge Gutierrez, Luis Mario Sosa, Reynaldo González, Luis Oñate, Juan Labardini
Journal: Blood
Blood (2016) 128 (22): 5362.
https://doi.org/10.1182/blood.V128.22.5362.5362
Published: 2016
Journal Articles

Nilotinib -Induced Retroperitoneal Fibrosis In a Patient with Chronic Myelogenous Leukemia.

Preeti Chaudhary, Haider Khadim, Teresa Gentile, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4495.
https://doi.org/10.1182/blood.V116.21.4495.4495
Published: 2010
Journal Articles

Hydralazine + Magnesium Valproate as Epigenetic Treatment for Myelodysplastic Syndrome (MDS). Preliminary Results of a Phase II Trial.

Myrna Candelaria, MD, Aquileo Herrera, MD, Juan Labardini, Sr., MD, Aurora Gonzalez-Fierro, Biol, Catalina Trejo-Becerril, MC, Erick de la Cruz-Hernandez, Dr, Brenda A la Torre-Talavera, Biol, Alfonso Duenas-Gonzalez, DR
Journal: Blood
Blood (2009) 114 (22): 1767.
https://doi.org/10.1182/blood.V114.22.1767.1767
Published: 2009
Journal Articles

Definition of Cytochrome P450 1A2 as a Target Autoantigen in the Hepatitic Variant of Hepatic Chronic Graft-Versus-Host Disease.

Charles G. Mullighan, MBBS, MSc, MD, Dimitrios Bogdanos, PhD, Diego Vergani, PhD, Peter G. Bardy, MBBS
Journal: Blood
Blood (2005) 106 (11): 1421.
https://doi.org/10.1182/blood.V106.11.1421.1421
Published: 2005